MedTrace Logo

Evaluate the Effects of Citicoline on Cognitive Performance in Healthy Adults

NCT06906848 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-07-09

No results posted yet for this study

Summary

Cognizin is a patented form of citicoline, a natural compound of the brain tissue.

It is believed that Cognizin can support brain function by boosting brain energy and protecting brain cells. Research suggests that Cognizin can improve different aspects of brain function and affects cognitive performance in healthy adults.

Conditions

  • Healthy
  • Cognitive Performance

Interventions

DIETARY_SUPPLEMENT

Placebo

Oral

DIETARY_SUPPLEMENT

Cognizin®

Oral

Sponsors & Collaborators

  • Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

    collaborator NETWORK

  • Kirin Holdings Company, Limited

    lead INDUSTRY

Principal Investigators

  • Dr.Koichiro Murashima · Kirin Holding Company Ltd. - Institute of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-20
Primary Completion
2025-05-31
Completion
2025-06-20

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06906848 on ClinicalTrials.gov